Related Experiment Video
Updated: Jun 29, 2026
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences
J M Castellano1, V M Navarro, J Roa
1Department of Cell Biology, Physiology, and Immunology, University of Córdoba, and CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain.
Endocrinology
|October 11, 2008
Summary
Defective hypothalamic KiSS-1 system function contributes to hypogonadism in diabetes. Kisspeptin administration can restore gonadotropin secretion in both male and female diabetic rats, suggesting therapeutic potential.
Area of Science:
- Reproductive Endocrinology
- Neuroendocrinology
- Diabetes Research
Background:
- Uncontrolled diabetes is linked to hypogonadism.
- The hypothalamic KiSS-1 system's role in diabetic hypogonadism is not fully understood, especially in females.
- Previous studies implicated defective KiSS-1 function in male diabetic hypogonadism.
Purpose of the Study:
- To investigate the temporal pattern of hypothalamic KiSS-1 system defects in diabetic rats.
- To explore the contribution of these defects to disturbed gonadotropin secretion in both sexes.
- To assess the therapeutic potential of kisspeptin in diabetic hypogonadism.
Main Methods:
- Streptozotocin (STZ)-induced diabetes model in male and female rats.
- Expression analysis of hypothalamic KiSS-1 mRNA.
- Hormonal level measurements (testosterone, gonadotropins).
- Hormonal response tests after orchidectomy (ORX) or ovariectomy (OVX).
- Administration of kisspeptin to assess LH and testosterone responses.
Main Results:
- Short-term diabetic males showed reduced testosterone and gonadotropin responses to ORX, linked to lower KiSS-1 mRNA. Kisspeptin normalized these responses.
- Long-term diabetic females exhibited anestrus, low gonadotropins, and blunted LH responses to OVX, associated with decreased KiSS-1 expression.
- Diabetic females maintained preserved or enhanced LH responses to kisspeptin, even with suppressed gonadotropins.
Conclusions:
- Altered hypothalamic KiSS-1 system function is temporally relevant in the hypogonadotropic state of uncontrolled diabetes in both sexes.
- Kisspeptin administration shows promise as an adjuvant therapy for managing disturbed gonadotropin secretion in type 1 diabetes, particularly in females.
More Related Videos
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...